183 related articles for article (PubMed ID: 2494912)
1. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.
Phillips M; Pugh GW; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912
[TBL] [Abstract][Full Text] [Related]
2. Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.
Pugh GW; Zehr ES; Meador VP; Phillips M; McDonald TJ; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):323-8. PubMed ID: 2494913
[TBL] [Abstract][Full Text] [Related]
3. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
[TBL] [Abstract][Full Text] [Related]
4. Brucella abortus-specific immunoglobulin in isotypes in serum and vaginal mucus from cattle vaccinated with strain 19 and challenge exposed with virulent strain 2308.
Hall SM; Confer AW; Patterson JM
Am J Vet Res; 1988 Jun; 49(6):840-6. PubMed ID: 3135769
[TBL] [Abstract][Full Text] [Related]
5. Chemical and protective properties of Brucella lipopolysaccharide obtained by butanol extraction.
Phillips M; Pugh GW; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):311-7. PubMed ID: 2494911
[TBL] [Abstract][Full Text] [Related]
6. Brucella abortus-specific immunoglobulin isotypes in serum and vaginal mucus from heifers vaccinated with Brucella abortus salt-extractable proteins and challenge exposed with virulent Brucella organisms.
Hall SM; Confer AW
Am J Vet Res; 1989 Dec; 50(12):1997-2003. PubMed ID: 2514615
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
Olsen SC
Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
[TBL] [Abstract][Full Text] [Related]
8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
9. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM
Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382
[TBL] [Abstract][Full Text] [Related]
10. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
[TBL] [Abstract][Full Text] [Related]
11. Establishment of dose-response relationships in BALB/c mice, using Brucella cell surface protein and lipopolysaccharide.
Pugh GW; Tabatabai LB; Phillips M; McDonald TJ
Am J Vet Res; 1991 Feb; 52(2):261-8. PubMed ID: 1901465
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW
Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273
[TBL] [Abstract][Full Text] [Related]
13. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
[TBL] [Abstract][Full Text] [Related]
15. Identification of a virulence factor for Brucella abortus infection in BALB/c mice.
Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; McDonald TJ; Zehr ES
Am J Vet Res; 1989 Jun; 50(6):887-92. PubMed ID: 2504086
[TBL] [Abstract][Full Text] [Related]
16. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308.
Pugh GW; Phillips M; Tabatabai LB; McDonald TJ
Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610
[TBL] [Abstract][Full Text] [Related]
17. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
[TBL] [Abstract][Full Text] [Related]
18. Liposome potentiation of humoral immune response to lipopolysaccharide and O-polysaccharide antigens of Brucella abortus.
Wong JP; Cherwonogrodzky JW; Di Ninno VL; Stadnyk LL; Knodel MH
Immunology; 1992 Sep; 77(1):123-8. PubMed ID: 1398758
[TBL] [Abstract][Full Text] [Related]
19. An enzyme immunoassay for bovine brucellosis using a monoclonal antibody specific for field strains of Brucella abortus.
Gorrell MD; Milliken GL; Anderson BJ; Pucci A
Dev Biol Stand; 1984; 56():491-4. PubMed ID: 6436107
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay for differentiation of the antibody response of cattle naturally infected with Brucella abortus or vaccinated with strain 19.
Nielsen K; Cherwonogrodzky JW; Duncan JR; Bundle DR
Am J Vet Res; 1989 Jan; 50(1):5-9. PubMed ID: 2465711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
